It is one of the most remarkable success stories of the pandemic: the unproven technology that delivered the Moderna and Pfizer/BioNTech vaccines in record time, helping to turn the tide on COVID-19. The vaccines are based on mRNA, the molecule that instructs our cells to make specific proteins.

Since his son was diagnosed with HIV during a mass outbreak in Pakistan among babies and children, hard-up Shahzado Shar has often been forced to choose between food and medicine.His five-year-old was one of hundreds who tested positive in 2019 after a whistle blower doctor uncovered a scandal involving the re-use of needles in southern Sindh province.The number of patients quickly swelled and two years later the figure stands at more than 1,500, according to data from the provincial health m

In the four decades since the first cases of what would come to be known as acquired immunodeficiency syndrome (AIDS) were documented, scientists have made huge strides in human immunodeficiency virus (HIV) treatment, transforming what was once a death sentence to a manageable condition.What we still don't have is a vaccine that would train human immune systems to ward off the infection before it ever takes root.Here's the state of play on some of these efforts, which experts see as

According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), HIV/AIDS in Indonesia is one of Asia’s fastest growing epidemics in recent years. As the world is currently battling a new coronavirus outbreak, old diseases such as the human immunodeficiency virus (HIV) remain a threat to many. It was reported that more than half a million Indonesians are living with HIV.

An Indonesian activist, who is also a doctor, recently revealed that people who have contracted the human immunodeficiency virus (HIV) in the country still face rampant stigmatisation and discrimination in the workplace.